1. Home
  2. BLZE vs ARDX Comparison

BLZE vs ARDX Comparison

Compare BLZE & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

BUY

Current Price

$9.12

Market Cap

762.0M

Sector

Technology

ML Signal

BUY

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$3.11

Market Cap

797.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
ARDX
Founded
2007
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
762.0M
797.8M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BLZE
ARDX
Price
$9.12
$3.11
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
★ $22.83
$12.90
AVG Volume (30 Days)
1.6M
★ 4.1M
Earning Date
11-02-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 58.56
N/A
EPS
★ N/A
N/A
Revenue
★ $145,835,000.00
$2,607,000.00
Revenue This Year
$18.60
$19.98
Revenue Next Year
$25.89
$27.70
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.27
N/A
52 Week Low
$3.26
$3.06
52 Week High
$23.99
$8.40

Technical Indicators

Market Signals
Indicator
BLZE
ARDX
Relative Strength Index (RSI) 27.06 33.33
Support Level $3.53 N/A
Resistance Level $9.46 $3.63
Average True Range (ATR) 0.81 0.12
MACD -0.48 0.01
Stochastic Oscillator 10.50 17.07

Price Performance

Historical Comparison
BLZE
ARDX

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: